Dodan Elementary School, The School of Achievers
July 10, 2021- end of School Year 2020-2021
July 12-16, 2021- schedule of End of School Year Rites
DepEd urges personnel in higher priority groups to register for COVID-19 vaccination
By: https://www.deped.gov.ph/2021/05/13/deped-launches-vacc2school-campaign-to-support-govts-vaccination-effort/
May 13, 2021 – To support the national vaccination drive of the government, the Department of Education (DepEd) launched Vacc2School: Ligtas na Bakuna, Para sa Balik-Eskwela! campaign for its teaching and non-teaching personnel.
Vacc2School campaign aims to inform, educate, and engage the Department’s stakeholders in promoting the vaccination drive and other related policies to mitigate COVID-19. The campaign was also contextualized to support the BIDA Solusyon Plus sa COVID-19 campaign of the Department of Health (DOH) in the education sector.
“I am encouraging everyone, especially the teachers, and other education personnel to participate in this campaign, and make informed decisions on vaccination to further intensify and advance our chances of safely returning to school,” Secretary Leonor Magtolis Briones, who recently received the vaccine herself, said.
“We would like to encourage our teachers to vaccinate themselves because it is not only a matter of protecting your personal rights, it is also a matter of protecting the lives and health of children which is also entrusted to our care,” she added.
Recently, the President and the IATF approved the request of Secretary Briones to include frontline personnel in basic education under Priority Group A4.
With the guidance of the NVDP, DepEd will participate in three levels: (1) as recipients or beneficiaries of the vaccine, (2) as members of the different task group on vaccination, and (3) as champions for advocacy of the immunization program.
Various materials will be launched throughout the campaign to maximize available platforms in communicating its objectives.
These materials are aligned on the Department’s messaging on vaccination participation focusing on the commitment to DepEd’s mandate, truth, health and safety, and promotion of informed decisions.
The campaign introduced the characters of Teacher Edna, Doctor Edu, Learners Kaye, and Sean in educating DepEd personnel and stakeholders on their roles in mitigating the virus.
Moreover, the Department created a microsite to serve as a repository of memoranda, aide-memoire, infographics, and other data in line with the campaign that may be accessed through the following link: deped.gov.ph/vacc2school.
By https://www.mayoclinic.org/coronavirus-covid-19/vaccine/comparing-vaccines
A coronavirus disease 2019 (COVID-19) vaccine can help you develop immunity to SARS-CoV-2, the virus that causes COVID-19, without getting ill. While each type of vaccine works in a different way, all COVID-19 vaccines prompt an immune response so that your body remembers how to fight the virus in the future.
The safety of the COVID-19 vaccines is being closely monitored by the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration (FDA). Even after a vaccine is authorized for use, vaccine safety monitoring systems continue to watch for side effects.
Here’s what you need to know about the different COVID-19 vaccines:
mRNA vaccine
95% effective at preventing the COVID-19 virus with symptoms
FDA emergency use authorization
Greater than 89% effective in preventing people with health conditions, such as diabetes or obesity, from developing the COVID-19 virus with symptoms
Doesn’t contain eggs, latex or preservatives
mRNA vaccine
94% effective at preventing the COVID-19 virus with symptoms
FDA emergency use authorization
Greater than 90% effective in preventing people with health conditions, such as diabetes or obesity, from developing the COVID-19 virus with symptoms
Doesn’t contain eggs, latex or preservatives
Vector vaccine
66% effective at preventing the COVID-19 virus with symptoms
85% effective at preventing the COVID-19 virus with severe illness
FDA emergency use authorization
Doesn’t contain eggs, latex or preservatives
Continues to be recommended by the FDA and CDC after a pause because the benefits outweigh the risks
Two doses are needed, 21 days apart (or up to six weeks apart, if needed)
Some protection provided after the first dose
Two doses are needed, 28 days apart (or up to six weeks apart, if needed)
Some protection provided after the first dose
One dose is needed
Some protection provided two weeks after vaccination
People age 16 and older should get the vaccine
People age 18 and older should get the vaccine
People who’ve had an immediate or severe allergic reaction to any of the vaccine’s ingredients or after a prior dose of the vaccine shouldn’t get the vaccine
People who’ve had an immediate allergic reaction to any vaccine or injectable medication should be cautious about getting the vaccine
People age 18 and older should get the vaccine
People who’ve had a severe allergic reaction to any of the vaccine’s ingredients and people who are allergic to polysorbate shouldn’t get the vaccine
Injection site pain, fatigue, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell and swollen lymph nodes
Injection site pain, fatigue, headache, muscle pain, chills, joint pain, swollen lymph nodes in the arm that was injected, nausea, vomiting and fever
Injection site pain, headache, fatigue, muscle pain, chills, fever and nausea
Note: If you received this vaccine within the last three weeks and are experiencing any unexplained new severe symptoms, seek emergency care.
Possible severe symptoms include shortness of breath, persistent stomach pain, severe or persistent headache, blurred vision, chest pain, leg swelling, easy bruising, and tiny red spots on the skin.
If you have any questions or concerns about getting a COVID-19 vaccine, talk to your doctor.